| 000 | 01563 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517200728.0 | ||
| 264 | 0 | _c20190517 | |
| 008 | 201905s 0 0 eng d | ||
| 022 | _a1557-7422 | ||
| 024 | 7 |
_a10.1089/hum.2017.241 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLi, Saisai | |
| 245 | 0 | 0 |
_aCD33-Specific Chimeric Antigen Receptor T Cells with Different Co-Stimulators Showed Potent Anti-Leukemia Efficacy and Different Phenotype. _h[electronic resource] |
| 260 |
_bHuman gene therapy _c05 2018 |
||
| 300 |
_a626-639 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aCytotoxicity, Immunologic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunotherapy, Adoptive |
| 650 | 0 | 4 |
_aLeukemia _xgenetics |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aReceptors, Chimeric Antigen _xgenetics |
| 650 | 0 | 4 |
_aSialic Acid Binding Ig-like Lectin 3 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 700 | 1 | _aTao, Zhongfei | |
| 700 | 1 | _aXu, Yingxi | |
| 700 | 1 | _aLiu, Jia | |
| 700 | 1 | _aAn, Na | |
| 700 | 1 | _aWang, Ying | |
| 700 | 1 | _aXing, Haiyan | |
| 700 | 1 | _aTian, Zheng | |
| 700 | 1 | _aTang, Kejing | |
| 700 | 1 | _aLiao, Xiaolong | |
| 700 | 1 | _aRao, Qing | |
| 700 | 1 | _aWang, Min | |
| 700 | 1 | _aWang, Jianxiang | |
| 773 | 0 |
_tHuman gene therapy _gvol. 29 _gno. 5 _gp. 626-639 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1089/hum.2017.241 _zAvailable from publisher's website |
| 999 |
_c28052623 _d28052623 |
||